[Clinical study of the assimilation, tolerance and metabolic effectiveness of protein products combined with a soybean isolate].
Combined product containing soybean isolate 500E (produced by "Ralston Purine Company", USA) were clinically used in 16 patients with hyperlipidemia, type II. The results obtained evidenced a high assimilability (95.5-95.9%) and pronounced hupocholesterolemic effect of the soybean isolate when it was used as a substitute for 2/3 or 1/2 protein volume in the ration.